Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.610
+0.004 (0.64%)
At close: Dec 5, 2025, 4:00 PM EST
0.600
-0.010 (-1.64%)
After-hours: Dec 5, 2025, 7:55 PM EST
Scienture Holdings Employees
As of December 31, 2024, Scienture Holdings had 19 total employees, including 14 full-time and 5 part-time employees. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$34,389
Profits / Employee
-$1,081,824
Market Cap
24.78M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19 | 0 | - |
| Dec 31, 2023 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SCNX News
- 4 days ago - SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025 - GlobeNewsWire
- 23 days ago - SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - SCIENTURE Announces Addition of Arbli™ (Losartan Potassium) to Formularies of Major National Health Plans - GlobeNewsWire
- 6 weeks ago - SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium) - GlobeNewsWire
- 7 weeks ago - SCIENTURE'S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers - GlobeNewsWire
- 7 weeks ago - Wellgistics Health Announces Executive Management and Board Changes - Accesswire
- 2 months ago - SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market - GlobeNewsWire
- 4 months ago - Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock - GlobeNewsWire